Abstract:BACKGROUNDThe p53 tumor suppressor protein is important in cell-cycle control, apoptosis, and DNA repair. Mutations in p53 have been associated with inherited cancer susceptibility. Because there is a difference in the risk of lung cancer among different ethnic groups, we examined associations between ethnicity and three polymorphisms in p53 (one exonic and two intronic) and haplotypes for the three loci and risk of lung cancer. We also examined the functionality of the p53 variants in apoptosis and DNA repair.METHODSIn a case-control study, we frequency matched (by age, sex, and ethnicity) 635 lung cancer case patients and 635 control subjects. p53 genotypes and haplotypes at the three polymorphic sites were determined by restriction fragment length polymorphism analysis of lymphocyte DNA. Odds ratios (ORs) and 95% confidence intervals (CIs) for the association between genotype or haplotype and lung cancer risk were determined by logistic regression analysis. Apoptosis and DNA repair capacity were measured in 22 lymphoblastoid cell lines to determine the functional effects of the polymorphisms. All statistical tests were two-sided.RESULTSGenotype and haplotype frequency distributions were strongly dependent on ethnicity; variant allele frequencies were highest in African-Americans (29.1%) and lowest in Mexican-Americans (12.2%). Each of the three polymorphisms was associated with an increased risk of lung cancer among all ethnic groups. Moreover, for all three polymorphisms, increased variant allele copy number was associated with increased risk of lung cancer. Similarly, the variant haplotypes were also associated with an increased risk for lung cancer. Lymphoblastoid cell lines with all wild-type alleles at the three loci had statistically significantly higher apoptotic indices (13.66%, 95% CI = 8.61% to 18.71%) and DNA repair capacity (27.63%, 95% CI = 21.72% to 33.53%) than cell lines with at least one variant allele at all three loci (3.50%, 95% CI = 1.08% to 5.91%; and 17.48%, 95% CI = 7.99% to 26.96%, respectively).CONCLUSIONSp53 polymorphisms may be associated with increased lung cancer risk and may affect p53 function.

Truncating Variants in P53aip1 Disrupting DNA Damage-Induced Apoptosis Are Associated with Prostate Cancer Risk

Association of selected polymorphisms of CCND1, p21, and caspase8 with colorectal cancer risk.

A Genetic Study and Meta-Analysis of the Genetic Predisposition of Prostate Cancer in a Chinese Population

Germline variant affecting p53β isoforms predisposes to familial cancer

TEX15: A DNA repair gene associated with prostate cancer risk in Han Chinese.

Susceptibility of XPD and Hogg1 Genetic Variants to Prostate Cancer

Clinical relevance of protein-truncating variants of germline DNA repair genes in prostate cancer

P53 Genotypes and Haplotypes Associated with Lung Cancer Susceptibility and Ethnicity.

Genetic Variations In A Pten/Akt/Mtor Axis And Prostate Cancer Risk In A Chinese Population

Germline DNA damage repair variants and prognosis of patients with high-risk or metastatic prostate cancer

Replication And Cumulative Effects Of Gwas-Identified Genetic Variations For Prostate Cancer In Asians: A Case-Control Study In The Chinapca Consortium

Synergistic Interaction of HOXB13 and CIP2A Predisposes to Aggressive Prostate Cancer.

Germline Variants in DNA Damage Repair Genes and HOXB13 Among Black Patients With Early-Onset Prostate Cancer

Polymorphisms in nucleotide excision repair genes and risk of primary prostate cancer in Chinese Han populations.

Genome-wide Association Study in Chinese Men Identifies Two New Prostate Cancer Risk Loci at 9q31.2 and 19Q13.4.

Characterising the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases

Genetic Variants in the TEP1 Gene Are Associated with Prostate Cancer Risk and Recurrence

Functional Polymorphisms in Cell Death Pathway Genes FAS and FAS Ligand and Risk of Prostate Cancer in a Chinese Population.

Identification of Genes with Rare Loss of Function Variants Associated with Aggressive Prostate Cancer and Survival

Association of Prostate Cancer Risk with SNPs in Regions Containing Androgen Receptor Binding Sites Captured by ChIP-On-chip Analyses.

Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis